Shandong Pharmaceutical Glass announced that on December 30, 2024, it received a notice from the controlling shareholder Luzhong Investment that the Yiyuan County People's Government and China International Pharmaceutical and Health Company are planning a reorganization of Luzhong Investment, which may involve a change in the controlling shareholder of Luzhong Investment, thereby leading to a change in the company's indirect controlling shareholder. The reorganization plan has not yet been finalized and requires approval from the relevant authorities, with the approval results being uncertain. Luzhong Investment's production and operation are normal, and this matter will not have a significant impact on its normal production and operation activities. The company will closely monitor the progress of the matter and fulfill its information disclosure obligations in a timely manner.